| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer
1 company
Krempa David serves as a Chief Business Officer at ETON. Across recent SEC filings that breaks down to 0 buys and 10 sells. Those positions are worth an estimated $2.4M at current prices.
Historically, Krempa David's trades have earned a below-average insider score of 10/100 across 3 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -100.0%.
The biggest single holding is ETON (~$2.4M) as Chief Business Officer. The recent filings there lean toward selling, a net 163,166 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | ETON Eton Pharmaceuticals, Inc. | Chief Business Officer | Sale+OE | 4,166 | $55.07 | $229,406.21 | -8.8% | - | - | |
| Aug 24, 2026 | ETON Eton Pharmaceuticals, Inc. | Chief Business Officer | Sale+OE | 25,000 | $65.07 | $1,626,750.00 | -40.3% | - | - | |
| May 27, 2026 | ETON Eton Pharmaceuticals, Inc. | Chief Business Officer | Sale+OE | 100,000 | $32.30 | $3,229,923.25 | -79.8% | +94.6% | - | |
| Jun 16, 2025 | ETON Eton Pharmaceuticals, Inc. | Chief Business Officer | Sell | 34,000 | $14.83 | $504,317.63 | -5.3% | +25.5% | +128.3% |